Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Manoel Carneiro de Oliveira Jr (São Paulo, Brazil), Manoel Carneiro de Oliveira Jr, Alana dos Santos Dias, Nicole Cristine Rigonato Oliveira, Auriléia Aparecida Brito, Erasmo Assumpção Neto, Elias El Mafarjeh, Nilsa Regina Damaceno Rodrigues, Marco Idzko, Ana Paula Ligeiro de Oliveira, Rodolfo de Paula Vieira. The anti-inflammatory effects of aerobic exercise in asthma is mediated by purinergic signaling. Eur Respir J 2016; 48: Suppl. 60, 698

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory effects of aerobic exercise in a murine model of asthma: Role of leukotrienes pathway Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Leukotrienes pathway are involved in the anti-inflammatory effects aerobic exercise on asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Aerobic exercise reduces asthma phenotype through inhibition of SOCS-JAK-STAT signaling in airway epithelium Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Aerobic exercise reduces asthma phenotype by inhibition of JAK2, SOCS3 and STAT6 in airway epithelium and in peribronchial leukocytes Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases Year: 2016 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Mechanisms underlying the role of exercise training as part of a weight loss program on asthma control in obese asthmatics Source: International Congress 2016 – Effects of exercise training interventions in chronic respiratory disease Year: 2016 Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Exercise induced broncho-constriction: from mechanism to clinical effects Source: Annual Congress 2013 –New ATS/ERS recommendations for bronchial challenge testing Year: 2013 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Autonomic dysregulation; a mechanism of asthma death Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016